TAMs enhance tumor progression by promoting genetic instability, angiogenesis, fibrosis, immunosuppression, lymphocyte rejection, invasion, and metastasis and promote the inflammatory environment by secreting cytokines, such as interleukin-17 (IL-17) and interleukin-23 (IL-23) (95, 96). Here, IL37 is linked to neoplasm.